Metraipolis › archive › dc_d1a24e72ff5e

Vitiligo-like depigmentation following neoadjuvant chemotherapy combined with pembrolizumab in early triple-negative breast cancer: a case report — Europe PMC PMID:42548621

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42548621
DOI
10.3389/fonc.2026.1817257
License (as archived)
solo-consultazione
Archived
2026-10-18T03:57:42.423Z
SHA-256 of the archived text
2873eea2a3bf20423a980dffb4653216ee47d5c4e889cec3cc063a77c04f23f2
Stable URL of this page
https://metraipolis.com/documento/dc_d1a24e72ff5e

How to cite

Vitiligo-like depigmentation following neoadjuvant chemotherapy combined with pembrolizumab in early triple-negative breast cancer: a case report — Europe PMC PMID:42548621 — Europe PMC (en), https://europepmc.org/article/MED/42548621 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d1a24e72ff5e (Metraipolis archive dc_d1a24e72ff5e, sha256 2873eea2a3bf20423a980dffb4653216ee47d5c4e889cec3cc063a77c04f23f2)
BibTeX
@misc{dcd1a24e72ff5e,
  title = {Vitiligo-like depigmentation following neoadjuvant chemotherapy combined with pembrolizumab in early triple-negative breast cancer: a case report — Europe PMC PMID:42548621},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42548621},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d1a24e72ff5e; sha256 2873eea2a3bf20423a980dffb4653216ee47d5c4e889cec3cc063a77c04f23f2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42548621. Agents can read the archived copy with the MCP tool read_document.